Search

You searched for "detachment"

1098 results found

Medical malpractice in uveitis: a review of clinical entities and outcomes

1 August 2018 | | EYE - Vitreo-Retinal
This paper presents a retrospective review of malpractice verdicts, rulings and settlements in the United States. Twenty-five cases of uveitis-related litigation spanning 1971-2014 were identified from the database representing 2.3% of all cases. Forty-eight percent of the cases were infectious....

Getting one’s eye in

4 February 2021 | | EYE - General
Lisette Bijma, Sister in the Eye Emergency Department at John Radcliffe Hospital, explains how COVID-19 provided a ‘baptism by fire’ and enabled fundamental and positive changes to the running of the department. Five years ago, I arrived in the UK,...

A paperless future – get involved!

1 August 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Jeremy Hunt’s statement earlier in 2014, about a paperless NHS by 2018, has added momentum to the transition away from paper records. The Tech Review this issue discusses what that will involve and how and why you may want to...

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 2)

1 February 2022 | | EYE - General
Are we doing enough to meet the current demands on ophthalmic services? In part two of a two-part series (see Part 1 here), Rosalind Harrison explains how efficiency can be improved by setting up eye services in community hubs. The...

Ophtherminator 3 - Rise of the Machines

3 June 2021 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...

Providing primary eyecare services during a global pandemic: the new normal

7 December 2020 | | EYE - General
It would be fair to say that 2020 hasn’t quite turned out to be the year that anyone predicted. Living with a global pandemic has become our reality and we are having to get used to many aspects of our...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

Cybersight: Clinical Technology & Surgical Techniques in the Evolving Management of Corneal Diseases

15 November 2024
The current state of the art in the diagnosis and treatment of corneal diseases depends on imaging techniques to visualize the morphology, 3D structure, and optical quality of the cornea. Improvements in imaging allow for increasingly individualized treatment of corneal...

ISS (International SPECTRALIS® Symposium) and Beyond

13 June 2025 -14 June 2025
We are pleased to invite you to the 21st edition of the International SPECTRALIS® Symposium – and Beyond (ISS), which will be held for the first time in Heidelberg, Germany, on June 13-14, 2025, at the new Congress Center, just...

MCLOSA: Annual Scientific Meeting 2025

28 November 2025
The Medical Contact Lens & Ocular Surface Association

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...